Archives

by in
Entry Author Date Location
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test 09/24/11 San Francisco
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News 09/22/11 Seattle
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic 09/21/11 Seattle
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News 09/08/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Xoma CEO Resigns After Four-Year Push To Go Commercial 08/31/11 San Francisco
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies 08/29/11 Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News 06/01/11 Boston
ImmunoGen Grabs $84M 05/20/11 Boston
SeaGen Ends March With $456M Cash 05/05/11 Seattle
Dyax, FivePrime Cut Antibody Deal 04/26/11 Boston
Genmab Expands SeaGen Alliance 04/19/11 Seattle
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol 03/02/11 Seattle
Amgen Pushes Ahead With ‘Son of Dmab’ For Treating Broken, Frail Bones 02/09/11 National
Secretive Biotech Arsanis Raises $9.6M 02/08/11 Boston
Seattle Genetics Reloads Cash Reserves With $155M, On Cusp of Selling First Drug 02/02/11 Seattle
Scripps President Richard Lerner To Step Down, Be Replaced by Berkeley Chemist, Sources Say 01/31/11 San Diego
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars 01/28/11 National
SEC Accuses Seattle Genetics Employee of Insider Trading 01/21/11 Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
Seattle Genetics Gets Some Love on National TV, as Cancer Drug Nears Market 01/14/11 Seattle
Entrega Emerges From Enlight 01/10/11 Boston
Xoma Nabs $35M Upfront Deal 01/04/11 San Francisco
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners 12/15/10 Boston
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s 12/05/10 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Montgomery Joins Alder Board 11/01/10 Seattle
PacBio’s $200M IPO, Ablexis’ 5-Way Big Pharma Deal, Codexis Morphs Into $100M Business, & More Bay Area Life Sciences News 10/29/10 San Francisco
Page 2 of 4 « previous page · next page »